We have very little insider data for Optimind Pharma Corp. (formerly Loon Energy Corporation) so far: the most recent filing dates from 16 January 2024. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
6 of 6 declarations
Optimind Pharma Corp. is a biopharmaceutical company focused on developing innovative treatments for neurological disorders. Formerly known as Loon Energy Corporation, it is listed on the Toronto Stock Exchange.